This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.


Selective Actions on Sleep or Anxiety by Exploiting GABA-A/Benzodiazepine Receptor Subtypes

Stephen M. Stahl

Published: March 1, 2002

Article Abstract

Are agents that act at benzodiazepine receptors making a comeback as anxiolytics? Benzodiazepines, once the most widely prescribed of all drugs, are still used to treat anxiety. All currently marketed benzodiazepines share rapid onset of sedativehypnotic, anxiolytic, anticonvulsant, and muscle relaxant properties. Choice of agent for each of these indications is largely a function of differential half-lives and marketing considerations rather than a consequence of any real selectivity of therapeutic action.

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 64

Quick Links: